Sweden· SE-20050422000021
Plasmalyte Glucos Infusionsvätska, lösning
A medicinal product containing magnesium chloride hexahydrate + potassium chloride + sodium chloride + glucose monohydrate + sodium acetate trihydrate + sodium gluconate, registered in Sweden by Baxter Medical AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Magnesium Chloride Hexahydrate + Potassium Chloride + Sodium Chloride + Glucose Monohydrate + Sodium Acetate Trihydrate + Sodium Gluconate
- Manufacturer
- Baxter Medical AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20050422000021
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Magnesium chloride hexahydrate + potassium chloride + sodium chloride + glucose monohydrate + sodium acetate trihydrate + sodium gluconate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPLASMALYTE S GLUKÓZOUBAXTER CZECH spol. s r.o., Praha
- CanadaACID CONCENTRATE A1267CHIEF MEDICAL SUPPLIES LTD
- NorwayGlucose-Na-K BaxterBaxter Medical AB
- FinlandGlucose-Na-K BaxterBaxter Oy
- IcelandPlasmalyte GlucosBaxter Medical AB*
- IrelandPlasma-Lyte 148 & Glucose 5% w/v solution for infusionBaxter Holding B.V.
- GermanyMaintelyteBaxter Deutschland Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Belgium · Plasmalyte 148, Plasmalyte 148 Viaflo
- Bulgaria · Гнак
- Cyprus · Maintelyte, Plasmalyte + Glucose 5%
- Czechia · Gnak, Plasmalyte S Glukózou
- Germany · Maintelyte
- Denmark · Glucose-Na-K Baxter, Plasmalyte
- Spain · Maintelyte, Viaflo Plasmalyte 148 Y Glucosa
- Finland · Glucose-Na-K Baxter, Plasmalyte Glucos
- France · Maintelyte, Plasmalyte Et Glucose
- United Kingdom (Northern Ireland) · Maintelyte, Plasma-Lyte 148
- Greece · Maintelyte, Plasmalyte + Glucose 5%
- Croatia · Gnak, Plasmalyte + Glucose
- Ireland · Maintelyte, Plasma-Lyte 148 & Glucose
- Iceland · Plasmalyte Glucos
- Italy · Crystalglu, Elettrolitica Bilanciata Di Mantenimento Con Glucosio Fresenius Kabi Italia
- Luxembourg · Plasmalyte 148 + Glucose Viaflo, Plasmalyte 148 Viaflo
- Malta · Maintelyte, Plasma-Lyte 148 & Glucose
- Netherlands · Maintelyte, Plasma-Lyte 148 + Glucose
- Norway · Glucose-Na-K Baxter, Karbolytt
- Poland · Gnak
- Portugal · Maintelyte, Plasma-Lyte 148 E Glucose Viaflo
- Romania · Gnak
- Slovenia · Gnak, Plasmalyte Z Glukozo
- Slovakia · Gnak, Plasmalyte + Glucose 5%
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/97c9213e-d57e-49dd-8e66-2ff1ed73db5d GET /v1/drugs/97c9213e-d57e-49dd-8e66-2ff1ed73db5d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20050422000021",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20050422000021",
"product_doc_link": "https://docetp.mpa.se/LMF/Plasmalyte%20Glucos%20solution%20for%20infusion%20SmPC_09001bee807a6ce1.pdf"
}See everything about magnesium chloride hexahydrate + potassium chloride + sodium chloride + glucose monohydrate + sodium acetate trihydrate + sodium gluconate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.